418
D.A. Niedbal, R. Madsen / Tetrahedron 72 (2016) 415e419
disappearance of the starting material by TLC (EtOAc/heptane, 2:5).
The mixture was then diluted with CH2Cl2 and washed with water
and brine. The organic layer was dried with Na2SO4 and concen-
trated. The residue was purified by column chromatography
(EtOAc/heptane, 2:5) to afford the pure glycosyl bromides as syrups
(80% yield of 1 and 74% yield of 6). NMR data were in accordance
with literature values.12
3.6. Phenyl 2,3,4,6-tetra-O-benzyl-
a-D-galactopyranosyl-
(1 / 6)-1-thio- -glucopyranoside (7)
b-D
Colorless oil. Rf 0.56 (CH2Cl2/MeOH 9:1); [
CHCl3); nmax (film) 3372, 2880, 1454, 1345, 1217, 1113, 1090, 967,
834, 749, 692 cmꢀ1
dH (400 MHz, CDCl3) 7.47e7.11 (m, 25H, Ar),
a
]
D
þ0.6 (c 0.5,
;
4.83 (d, J¼11.4 Hz, 1H, OCH2Ph), 4.75 (d, J¼4.1 Hz, 1H, H-10), 4.74 (d,
J¼11.7 Hz, 1H, OCH2Ph), 4.71 (d, J¼11.7 Hz, 1H, OCH2Ph), 4.63 (d,
J¼11.7 Hz, 1H, OCH2Ph), 4.56 (d, J¼11.9 Hz, 1H, OCH2Ph), 4.46 (d,
J¼11.5 Hz, 1H, OCH2Ph), 4.42 (d, J¼9.7 Hz, 1H, H-1), 4.38 (d,
J¼11.8 Hz, 1H, OCH2Ph), 4.31 (d, J¼11.8 Hz, 1H, OCH2Ph), 3.95 (dd,
J¼9.4, 3.8 Hz, 1H, H-20), 3.93e3.82 (m, 3H, H-40, H-50, H-6a), 3.79
(dd, J¼9.6, 3.5 Hz, 1H, H-30), 3.51 (dd, J¼10.3, 4.7 Hz, 1H, H-6b),
3.47e3.35 (m, 5H, H-3, H-4, H-5, H-6a0, H-6b0), 3.28e3.19 (m, 1H, H-
2); dC (100 MHz, CDCl3) 138.7, 138.5, 138.1, 137.7, 132.8, 130e127
(Ar), 98.5 (C-10), 87.7 (C-1), 79.1 (C-30), 77.6 (C-3), 77.3 (C-40), 76.3
(C-20), 74.8 (2ꢂOCH2Ph), 73.7 (C-50), 73.5 (OCH2Ph), 73.1 (OCH2Ph),
72.0 (C-5), 71.7 (C-2), 69.7 (C-4), 69.1 (C-60), 68.9 (C-6); HRMS calcd
for C46H50O10S [MþNa]þ m/z 817.3022, found 817.3026.
3.3. General procedure for tin-mediated regioselective
glycosylation
A suspension of the unprotected hexopyranoside (0.5 mmol)
and Bu2SnO (0.5 mmol) in MeOH (3.0 mL) was heated to reflux until
a clear solution was obtained (3 h). The solvent was removed in
vacuo followed by drying under high vacuum for 6 h to give the
stannylene derivative as a colorless foam. The bromide donor
ꢀ
(0.9 mmol) and 4 A molecular sieves (300 mg) were then added to
a solution of the stannylene derivative in CH2Cl2 (2 mL). The sus-
pension was stirred at room temperature for 15 min. Tetrabuty-
lammonium bromide (0.9 mmol) was then added and the mixture
was stirred in the dark for the time indicated. The mixture was
diluted with CH2Cl2, filtered and concentrated. The crude product
was purified by column chromatography (toluene/acetone 3:1) or
(CH2Cl2/MeOH 95:5 / 90:10) to afford the pure disaccharide.
3.7. Phenyl 2,3,4,6-tetra-O-benzyl-
a-D-galactopyranosyl-
(1 / 6)-1-thio- -galactopyranoside (8)
b-D
Colorless oil. Rf 0.54 (CH2Cl2/MeOH 9:1); [
a
]
D
þ0.9 (c 0.5,
CHCl3); nmax (film) 3423, 1453, 1113, 1025, 868, 743, 693 cmꢀ1
;
dH
(400 MHz, CDCl3) 7.49e7.04 (m, 25H, Ar), 4.88 (d, J¼3.7 Hz, 1H, H-
10), 4.83 (d, J¼11.4 Hz, 1H, OCH2Ph), 4.74 (d, J¼11.8 Hz, 1H, OCH2Ph),
4.70 (d, J¼11.8 Hz, 1H, OCH2Ph), 4.64 (d, J¼11.7 Hz, 1H, OCH2Ph),
4.61 (d, J¼11.8 Hz, 1H, OCH2Ph), 4.46 (d, J¼11.4 Hz, 1H, OCH2Ph),
4.39 (d, J¼9.5 Hz, 1H, H-1), 4.37 (d, J¼11.6 Hz, 1H, OCH2Ph), 4.30 (d,
J¼11.7 Hz, 1H, OCH2Ph), 3.96 (dd, J¼9.4, 3.7 Hz, 1H, H-20), 3.93e3.82
(m, 4H, H-2, H-40, H-50, H-6a), 3.78 (dd, J¼9.6, 2.7 Hz, 1H, H-30), 3.68
(dd, J¼10.9, 5.3 Hz, 1H, H-6b), 3.59e3.37 (m, 5H, H-3, H-4, H-5, H-
6a0, H-6b0); dC (100 MHz, CDCl3) 138.6, 138.6, 138.1, 137.9, 132.8,
133e127 (Ar), 98.7 (C-10), 88.6 (C-1), 78.9 (C-30), 77.2 (C-20), 76.2 (C-
40), 74.8 (C-3), 74.7 (C-50), 73.8 (OCH2Ph), 73.5 (OCH2Ph), 72.9
(2ꢂOCH2Ph), 70.1 (C-5), 69.7 (C-2), 69.2 (C-4), 69.0 (C-60), 67.8 (C-
6); HRMS (ESI) calcd for C46H50O10S [MþNa]þ m/z 817.3022, found
817.3012.
3.4. Phenyl 2,3,4,6-tetra-O-benzyl-
a-D-glucopyranosyl-
(1 / 6)-1-thio- -glucopyranoside (3)
b-D
Colorless oil. Rf 0.54 (CH2Cl2/MeOH 9:1); [
a
]
þ0.8 (c 0.3,
D
CHCl3); nmax (film) 3318, 1454, 1114, 1026, 836, 530 cmꢀ1
;
dH
(400 MHz, CDCl3) 7.53e6.98 (m, 25H, Ar), 4.86 (d, J¼10.9 Hz, 1H,
OCH2Ph), 4.74 (d, J¼10.9 Hz, 1H, OCH2Ph), 4.69 (d, J¼10.9 Hz, 1H,
OCH2Ph), 4.67 (d, J¼3.3 Hz, 1H, H-10), 4.66 (d, J¼10.9 Hz, 1H,
OCH2Ph), 4.54 (d, J¼12.1 Hz, 1H, OCH2Ph), 4.51 (d, J¼12.1 Hz, 1H,
OCH2Ph), 4.43 (d, J¼9.5 Hz, 1H, H-1), 4.39 (d, J¼9.7 Hz, 1H, OCH2Ph),
4.38 (d, J¼9.7 Hz, 1H, OCH2Ph), 4.02e3.79 (m, 2H, H-30, H-6a),
3.78e3.35 (m, 9H, H-20, H-3, H-5, H-50, H-4, H-40, H-6b, H-6a0, H-
6b0), 3.24 (dd, J¼9.0, 8.1 Hz, 1H, H-2); dC (100 MHz, CDCl3) 138.7,
138.2, 137.9, 137.8, 132.9, 132e127 (Ar), 97.9 (C-10), 88.1 (C-1), 82.1
(C-30), 79.7 (C-20), 77.6 (C-40), 77.5 (C-3), 77.2 (C-50), 75.8 (OCH2Ph)
75.1 (OCH2Ph), 73.5 (2ꢂOCH2Ph), 72.1 (C-5), 71.7 (C-2), 70.5 (C-4),
69.0 (C-60), 68.5 (C-6); HRMS (ESI) calcd for C46H50O10S [MþNa]þ
m/z 817.3022, found 817.2997.
3.8. Methyl 2,3,4,6-tetra-O-benzyl-a-D-galactopyranosyl-
(1 / 6)- -glucopyranoside (18)
a-D
Colorless oil. Rf 0.51 (CH2Cl2/MeOH 9:1); [
a]
D þ5 (c 0.6, CHCl3);
dH (400 MHz,
nmax (film) 3381, 1452, 1114, 1024, 965, 546 cmꢀ1
;
3.5. Phenyl 2,3,4,6-tetra-O-benzyl-
a-D-glucopyranosyl-
CDCl3) 7.36e6.13 (m, 20H, Ar), 4.85 (d, J¼11.5 Hz, 1H, OCH2Ph), 4.77
(d, J¼12.0 Hz, 1H, OCH2Ph), 4.73 (d, J¼11.5 Hz, 1H, OCH2Ph), 4.71 (d,
J¼2.5 Hz, 1H, H-10), 4.65 (d, J¼11.6 Hz, 1H, OCH2Ph), 4.64 (d,
J¼3.5 Hz, 1H, H-1), 4.58 (d, J¼12.0 Hz, 1H, OCH2Ph), 4.48 (d,
J¼11.6 Hz, 1H, OCH2Ph), 4.40 (d, J¼11.8 Hz, 1H, OCH2Ph), 4.30 (d,
J¼11.8 Hz, 1H, OCH2Ph), 3.96 (dd, J¼9.4, 3.8 Hz, 1H, H-20), 3.90e3.80
(m, 4H, H-2, H-3, H-30, H-6a), 3.67e3.58 (m, 2H, H-4, H-40),
3.52e3.31 (m, 5H, H-5, H-50, H-6b, H-6a0, H-6b0), 3.29 (s, 3H, OCH3);
dC (100 MHz, CDCl3) 138.6, 138.5, 138.3, 137.6, 133e127 (Ar), 99.1 (C-
1), 98.8 (C-10), 79.1 (C-30), 76.2 (C-2), 74.8 (C-3), 74.7 (C-40), 74.3
(OCH2Ph), 73.8 (OCH2Ph), 73.6 (OCH2Ph), 73.1 (OCH2Ph), 72.3 (C-5),
72.0 (C-50), 70.0 (C-20), 69.4 (C-4), 69.3 (C-60), 69.2 (C-6); HRMS
(ESI) calcd for C41H48O11 [MþNa]þ m/z 739.3094, found 739.3082.
(1 / 6)-1-thio- -galactopyranoside (5)
b-D
Colorless oil. Rf 0.55 (CH2Cl2/MeOH 9:1); [
a
]
þ0.6 (c 0.4,
D
CHCl3); nmax (film) 3452, 1452, 1141, 1025, 881, 740, 694 cmꢀ1
;
dH
(400 MHz, CDCl3) 7.48e7.00 (m, 25H, Ar), 4.87 (d, J¼11.7 Hz, 1H,
OCH2Ph), 4.86 (d, J¼3.7 Hz, 1H, H-10), 4.75 (d, J¼10.7 Hz, 1H,
OCH2Ph), 4.74 (d, J¼10.7 Hz, 1H, OCH2Ph), 4.70 (d, J¼11.6 Hz, 1H,
OCH2Ph), 4.61 (d, J¼11.9 Hz, 1H, OCH2Ph), 4.52 (d, J¼12.1 Hz,
OCH2Ph), 4.42 (d, J¼9.7 Hz, 1H, H-1), 4.41 (d, J¼12.1 Hz, 1H,
OCH2Ph), 4.37 (d, J¼12.1 Hz, 1H, OCH2Ph), 4.00e3.68 (m, 5H, H-30,
H-40, H-5, H-6a, H-6b), 3.68e3.42 (m, 7H, H-2, H-20, H-3, H-4, H-50,
H-6a0, H-6b0); dC (100 MHz, CDCl3) 138.6, 138.2, 137.9, 137.8, 132.5,
132e127 (Ar), 98.0 (C-10), 88.9 (C-1), 81.9 (C-30), 79.6 (C-20), 77.6 (C-
5), 77.2 (C-40), 75.7 (OCH2Ph), 75.1 (OCH2Ph) 74.7 (C-3), 73.5
(2ꢂOCH2Ph), 70.6 (C-5), 70.2 (C-2), 69.2 (C-4), 68.4 (C-60), 67.8 (C-
6); HRMS (ESI) calcd for C46H50O10S [MþNa]þ m/z 817.3022, found
817.3004.
Acknowledgements
We thank The Novo Nordisk Foundation for financial support.